ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
2
- 0 vs. Q1 2026
- Total value $2
Superinvestors holding PRPH
0
- None of the superinvestors held PRPH at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by PRPH insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022Amended | Mar 10, 2022 | Barr Jason MichaelDirector | PPurchaseCommon Stock, par value $0.0005 | +721 | $6.48 | +$4.67K | 30.96K | +2.4% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in PRPH at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CoreCap Advisors, LLC | 10 | $1 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 10 | $1 | 0.00% | 00.0% | Unchanged |